Drug intelligence / Profile preview

Dermidoc

Development stage: Preclinical
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Dermidoc is a topical cream developed for the treatment of atopic dermatitis (AD), a chronic inflammatory skin condition also known as eczema. Clinical studies have shown that Dermidoc cream significantly improves skin symptoms associated with AD and is well tolerated. In a study involving 100 patients, Dermidoc demonstrated superior efficacy compared to a PolymixinB-bacitrin group in ameliorating AD symptoms.

Brand names: Dermi DocDermi Doc Anti Acne CreamHerbion Dermi Doc Anti-Acne Cream
Other names: Dermidoc cream

Beyond the preview

Go deeper on Dermidoc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dermidoc.

Explore the full profile